Summary &horbar; For some years, research in the field of growth endocrinology has been mainly focused on growth hormone (GH). However, it appears that GH does not always control growth rate. For instance, it does not clearly influence intra-uterine growth : moreover, although the results of GRF or GH administration appear convincing in rats, pigs or heifers, this is not the case in chickens and lambs. In addition, GH does not always clearly stimulate somatomedin production, particularly diring food restriction and fetal life, and in hypothyroid animals or sex-linked dwarf chickens. In such situations, this phenomenon is associated with a reduced T3 production, suggesting a significant influence of thyroid function on GH action, and more generally, on body growth. In fact, numerous data demonstrate that thyroid hormone is strongly involved in the regulation of body growth. In species with low maturity at birth, such as the rat. T4 and T3 affect postnatal growth eleven days earlier than the appearance of GH influence. In contrast to GH, thyroid hormone significantly influences fetal growth in sheep. Moreover, the body growth rate is clearly stimulated by T3 in dwarf animals. In addition to its complex metabolic effects involved in the general mechanisms of body growth, thyroid hormone stimulates the production of growth factors, particularly EGF and NGF. Moreover, it affects GH and somatomedin production and also their tissue activity. All these results strongly suggest that it would be difficult to study GH regulation and physiological effects without taking thyroid function into account. body growth &horbar; thyroid hormone &horbar; GH &horbar; GRF &horbar; IGF Résumé &horbar; Hormones thyroïdiennes et croissance. Interactions avec l'axe somatotrope. Depuis plusieurs années, les recherches concernant l'endocrinologie de la croissance sont particulièrement orientées sur l'hormone de croissance (GH). Il semble cependant que le GH ne contrôle pas la croissance dans toutes les situations. Ainsi, elle ne semble pas influencer la croissance intra-utérine; de plus, si les résultats de l'administration de GRF ou de GH sont convaincants chez le rat, le porc ou le bovin, ils s'avèrent plus décevants chez le poulet ou le mouton. D'autre part, la GH n'induit pas toujours une stimulation de la production de somatomédines, notamment pendant la vie intra-utérine, au cours de la restriction alimentaire, ainsi que chez les animaux hypothyroitiiens et chez les poulets nains (nanisme lié au sexe). Dans toutes ces situations particulières, la déficience de stimulation des somatomédines par la GH est associée à une production réduite de T3, ce qui suggère une influence significative de la fonction thyroïdienne sur les effets de la GH, et plus généralement sur la croissance. En fait, de nombreux résultats démontrent que les hormones thryoïdiennes sont impliquées dans la régulation de la croissance corporelle. Chez les espèces à faible maturité à la naissance telles que le rat, la T4 et la T3 influencent la croissance postnatale bien avant que la GH ait un effet significatif. De plus, contrairement à la GH, les hormones thyroïdiennes affectent la croissance foetale chez le mouton. D'autre part, la croissance corporelle est significativement stimulée par la T3 chez les animaux nains. En plus de leurs effets métaboliques complexes qui participent aux mécanismes généraux de la croissance corporelle, les hormones thyroïdiennes stimulent la production de facteurs de croissance tels que le NGF ou l'EGF. Elles influencent également la production de GH et de somatomédines, ainsi que leurs activités tissulaires. Tous ces résultats suggèrent qu'il serait difficile d'étudier la régulation de l'axe somatotrope et ses conséquences physiologiques, en particulier sur la croissance, sans tenir compte de la fonction thyroïdienne.
In all animals studied such as mice (Eguchi, 1961) and rats (Jost, 1977) , lack of circulating GH, induced by decapitation, did not affect fetal growth. Moreover, the influence of pituitary destruction upon body growth is not detectable before the 25th day of extra-uterine life in rats (Walker et al., 1950) , and is even more delayed in rabbits (V6zhinet, 1968) .
In the fetal lamb, the situation needs some clarification. It is generally assumed that hypophysectomy, performed between days 100 and 112 of pregnancy in sheep fetuses, does not reduce the birthweight of lambs (Jones et al., 1985; Parkes, 1985) . However, in similar experimental conditions, we have observed that fetal pituitary destruction was associated with a 30% reduction of the birthweight (Wrutniak et aL, 1985) . Hypophysectomy, like thyroidectomy, results in very low plasma thyroid hormone levels in lamb fetuses, and thyroidectomy induces a similar reduction of the birthweight (Hopkins & Thorburn, 1972; Bhakthavathsalan et al., 1981) without suppression of the levels of other pituitary hormones or other hormones influenced by the pituitary. Therefore, in our opinion, the effect of hypophysectomy recorded in our work could be due to a thyroid hormone deficiency. However, in this hypothesis, the observation by other researchers that fetal pituitary destruction fails to affect intra-uterine growth, is not clear and needs further study.
It could be assumed that the influence of fetal GH on intra-uterine growth may be masked by a significant production of placental GH. Such a placental factor was identified in pregnant women by Frankenne etaL (1987) . However, no evidence was provided that this GH could reach the fetus. Moreover, such a possibility does agree with the observation that rat and rabbit body growth is not sensitive to pituitary destruction before days 25 and 100 of extra-uterine life (V6zinhet, 1968; Walker et al., 1950 (Petitclerc et al., 1987) . However, the mode of administration is important : Kensinger et al. (1987) have shown that the administration of the same amount/ day of GRF is more effective in raising GH levels in lambs when performed using four to eight daily injections, than using only two injections or continuous infusion. Moreover, in steers, Moseley et al. (1984) have shown that the pulsatile administration of GRF is able to increase GH secretion without desensitization for at least 5 days. Therefore, bearing the mode of GRF administration in mind, the effects of GH and GRF administration upon body growth should be considered together.
GRF administration could be effective in improving body growth in rats. Pulsatile injections of GRF every 3 h for 12 days, increased the body growth of the young by = 30% (Clark & Robinson, 1985) . On the other hand, Wehrenberg (1986) (Boyd et aL, 1986; Campbell et aL, 1988; Chung et al., 1985; Etherton et aL, 1986; 1987) , or recombinant porcine GH (Evock et al., 1988) , increases pig growth performance. Despite differences between studies, GH seems to increase the average daily gain from 10% to 20%, and to improve feeding efficiency from 15% to 35%.
In
Belgian white blue heifers, subcutaneous GH injections, once a day for 8 weeks, increased weight gain by 21% and also feeding efficiency (Fabry et al., 1985; 1987) . Moreover, Closset et al. (1986) (Koritnik et al., 1981) , ), the chicken (Falconner et al., 1981) and man (Grant et al., 1973) (Baxter et al., 1981; Postel-Vinay et aL, 1982; Maes et aL, 1986) .
A similar dissociation between GH and somatomedin-C/IGF1 is apparent during intra-uterine life. After the 100th day of pregnancy, the plasma level of GH is about 10 times higher in the ovine fetus than in its mother (Basset et aL, 1970; Bassett & Gluckman, 1986; Lowe et aL, 1986 ) and the secretion of this hormone is characterized by a markedly exaggerated pulsatile release (Gluckman, 1985) ; however, the plasma concentrations of IGF1 are very low (Gluckman & Butler, 1985) . Moreover, as decapitation did not influence plasma IGF1 levels (Gluckman, 1985) , IGF1 production is not obviously dependent on GH regulation. The situation is the same in human fetuses, where plasma IGF1 levels are similar to those observed in adults with total GH deficiency (Lassare et aL, 1986 ). At birth, the level of GH in neonates is about ten times higher than in adults, whereas, concentrations of somatomedin-C are five times lower (Nagashima et al., 1986) . As in sheep, fetal IGF1 production does not seem to be regulated by GH secretion (Sara & Carlsson-Skwirut, 1986) .
In sex-linked dwarf chickens, plasma GH levels are also higher than in normal animals (Hoshino & Yamamoto, 1977; Hoshino et al., 1982; Scanes et al., 1983; Huybrechts et al., 1987) , but the levels of somatomedin C are lower (Hoshino et al., 1982; Huybrechts ef al., 1985; 1987) . This could be explained by a reduction in growth hormone receptor binding (Leung et al., 1987) .
Hypothyroidism is associated with a comparable situation. If, in hypothyroid rats, plasma GH and IGF levels are significantly lowered, GH administration does not restore IGF1 concentrations (Burstein et al., 1979) . Similarly, plasma levels of somatomedin-C are decreased in hypothyroid chickens despite normal GH concentrations (Decuypere et al., 1987) . T3 deficiency in situations in which GH does not increase somatomedin production In the preceding situations in which GH apparently does not increase somatomedin-C/IGF1 production, T3 deficiency simultaneously occurred.
In all animals studied, food restriction was associated with a considerable reduction of plasma T3 levels, such as in man (Burman et al., 1979; Marugo et ai., 1984; Suda et al. 1978) , calves (Blum & Kunz, 1981; Tveit & Larsen, 1983) and adult (Blum et al., 1980) or newborn sheep (Wrutniak & Cabello, 1987a ). This decrease in T3 production could be explained not only by a lowered TSH secretion (Burger et al., 1981; Hugues et aL, 1984; R6jdmark & Nygren, 1983; Tveit & Almlid, 1980; Wrutniak & Cabello, 1987a) , but also by an inhibition of the peripheral conversion of T4 into T3 (Balsam & Ingbar, 1979; Chopra, 1980; Gavin & Moeller, 1983 ).
In the ovine fetus, plasma T3 levels are very low during the major part of the pregnancy, in parallel with a reduced T3 thyroid secretion (Klein et al., 1980) , and a marked inactivity of cellular 5'-deiodinases (Wu et aL, 1986) . They progressively rose only after the 130 th day of gestation (Klein et al., 1978; Wrutniak et aL, 1985) . Similarly, in the human fetus, T3 levels remain undetectable until the 30 th week of pregnancy and rise during the last 10 weeks. At birth, they are three times lower than those measured in the mother (Fisher et al., 1977 Moreover, Hoshino et al. (1986) have observed that, despite a large increase in plasma T4 levels after TRH administration, plasma T3 levels did not rise in these animals, suggesting a depressed T4 to T3 conversion. As in chickens growth hormone could induce stimulation of 5'-deiodinases (Kuhn et aL, 1986a, b) ; the diminished hepatic growth hormone binding reported in such animals (Leung et al., 1987) (Utiger, 1979) .
Thyroid hormone influences the fetal growth
In species with low maturity at birth, the fetal growth is apparently independent of thyroid function, as in the rabbit (Jost et al., 1958) or the rat (Cooke et al., 1984; Jost, 1969; Jost & Picon, 1970 (Holt et aL, 1973; Kerr et al., 1972) . Similarly, in the fetal lamb, a thyroid hormone deficiency, linked to poor maternal iodine intake, was associated with a 20% reduction in the birthweight (Setchell et al., 1960 Similarly, intra-uterine growth retarted lambs displayed T4 and T3 deficiencies during at least the first month of life (Wrutniak & Cabello, 1987b; (Brown, 1966; Goldberg, 1978) or influence on energy management (Van Hardeveld, 1986) . In order to obtain valuable information on this topic, readers should refer to general reviews such as those of Ramsden (1977) (Walker et aL, 1979; 1981b) Leonard & Visser, 1986) (1981) The effects of fetal thyroidectomy during the second trimester in ovine fetus. Am. J. Obstet. Gynecol. 14, [436] [437] [438] [439] [440] [441] [442] Binoux M., Faivre-Bauman A., Lassarre C., Barret A. & Tixier-Vidal A. (1985) 
